UBS Group’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112M | Buy |
1,186,181
+923,327
|
|
||||
|
2025
Q1 | $16.7M | Sell |
262,854
-110,551
|
|
||||
|
2024
Q4 | $17.3M | Buy |
373,405
+238,837
|
|
||||
|
2024
Q3 | $3.87M | Buy |
134,568
+31,689
|
|
||||
|
2024
Q2 | $1.49M | Buy |
102,879
+101,044
|
|
||||
|
2024
Q1 | $29.5K | Sell |
1,835
-179
|
|
||||
|
2023
Q4 | $40K | Sell |
2,014
-1,323
|
|
||||
|
2023
Q3 | $54.4K | Buy |
3,337
+332
|
|
||||
|
2023
Q2 | $63.5K | Sell |
3,005
-2,427
|
|
||||
|
2023
Q1 | $109K | Buy |
5,432
+1,263
|
|
||||
|
2022
Q4 | $109K | Buy |
4,169
+3,391
|
|
||||
|
2022
Q3 | $8K | Buy |
+778
|
|
||||
|
2022
Q2 | – | Sell |
-655
|
|
||||
|
2022
Q1 | $3K | Buy |
+655
|
|
||||
|
2021
Q4 | – | Sell |
-879
|
|
||||
|
2021
Q3 | $5K | Buy |
+879
|
|
||||
|
2021
Q2 | – | Sell |
-1,407
|
|
||||
|
2021
Q1 | $12K | Sell |
1,407
-316
|
|
||||
|
2020
Q4 | $12K | Buy |
1,723
+327
|
|
||||
|
2020
Q3 | $9K | Buy |
+1,396
|
|
||||
|
2020
Q2 | – | Sell |
-4,000
|
|
||||
|
2020
Q1 | $16K | Sell |
4,000
-6,055
|
|
||||
|
2019
Q4 | $58K | Buy |
10,055
+8,940
|
|
||||
|
2019
Q3 | $5K | Sell |
1,115
-272
|
|
||||
|
2019
Q2 | $7K | Buy |
+1,387
|
|
||||
|
2019
Q1 | – | Sell |
-138
|
|
||||
|
2018
Q4 | $1K | Buy |
+138
|
|
||||
|
2018
Q2 | – | Sell |
-703
|
|
||||
|
2018
Q1 | $14K | Buy |
703
+702
|
|
||||
|
2017
Q4 | $0 | Buy |
+1
|
|